Join us to examine cybersecurity risks associated with medical device technology and the strategies and policies that can help address such risks.
The Bipartisan Policy Center applauds the Senate HELP Committee for passing the Food and Drug Administration Reauthorization Act of 2017.
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.
While ideological divides on health care policy remain wide, the next Congress and administration will face several key issues that will require bipartisan collaboration to address.
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
BPC has released a number of reports that included recommendations to better organize and integrate our health care system to lower costs and improve quality of care.
BPC kicked off its FDA: Advancing Medical Innovation initiative, with the first session addressing how to accelerate the discovery, development and delivery of medical products.